The content on this site is intended for healthcare professionals only
Prof Francesco Cosentino speaks to ecancer at the International Aspirin Foundation Scientific Conference 2019 in Rome about the guidelines surrounding the use of aspirin in patients with diabetes.
He discusses which patients might benefit from using aspirin, but points out that the guidelines governing this are controversial.
Prof Cosentino mentions the ASCEND trial, which aims to investigate the use of aspirin as a preventative measure in diabetic patients.
Read more on the highlights from the 2019 International Aspirin Foundation Scientific Conference here.
KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
OncoAlert Round Up for September 15-21, 2023
The Southeast Asian Breast Cancer Symposium; background, aims and successes
OncoAlert Round Up for August 25th - 31st, 2023
OncoAlert Round Up for August 4th - 10th, 2023
Time toxicity: the burden on cancer patients
The current status of multiple myeloma diagnosis and treatment
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
